AI assistant
Sending…
Medpace Holdings, Inc. — Director's Dealing 2018
Aug 7, 2018
30442_dirs_2018-08-06_7a17c6ac-4266-40cb-a0c9-32c1a05dc231.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2018-08-02
Reporting Person: GEIGER JESSE J (CFO & COO, Lab Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-02 | Common Stock | S | 7407 | $60.15 | Disposed | 0 | Direct |
Footnotes
F1: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.15 to $60.28 per share. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
More from Medpace Holdings, Inc.
Board/Management Information
2026
Jun 4
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 22
Annual Report
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 18